Related references
Note: Only part of the references are listed.Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial
H. Neighbour et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Monoclonal antibodies for the treatment of refractory asthma
Nathan Hambly et al.
CURRENT OPINION IN PULMONARY MEDICINE (2014)
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia
Hector Ortega et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Innate lymphoid cells and asthma
Sanhong Yu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Anti-Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma
Parameswaran Nair
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Eosinophilic granulomatosis with polyangiitis (ChurgStrauss): state of the art
A. Vaglio et al.
ALLERGY (2013)
Development and function of group 2 innate lymphoid cells
Jennifer A. Walker et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
What is an eosinophilic phenotype of asthma?
Parameswaran Nair
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
TH2, allergy and group 2 innate lymphoid cells
Paula Licona-Limon et al.
NATURE IMMUNOLOGY (2013)
Eosinophilic airway inflammation in nonallergic asthma
Guy G. Brusselle et al.
NATURE MEDICINE (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeted therapy of bronchitis in obstructive airway diseases
Angira Dasgupta et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Anti-interleukin-5 therapy in severe asthma
Gilles Garcia et al.
EUROPEAN RESPIRATORY REVIEW (2013)
Interleukin-4 and interleukin-13 prime migrational responses of haemopoietic progenitor cells to stromal cell-derived factor-1α
N. Punia et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Eosinophilic Pneumonias
Praveen Akuthota et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
How to Diagnose and Phenotype Asthma
Parameswaran Nair et al.
CLINICS IN CHEST MEDICINE (2012)
Benralizumab - a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity - a novel approach for the treatment of asthma
Aasia Ghazi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
The potential of biologics for the treatment of asthma
Girolamo Pelaia et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study
Mario Castro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Targeting Interleukin-5 in Refractory and Relapsing Churg-Strauss Syndrome
Frank Moosig et al.
ANNALS OF INTERNAL MEDICINE (2011)
Eosinophils in health and disease: the LIAR hypothesis
J. J. Lee et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2010)
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Sustained response to mepolizumab in refractory Churg-Strauss syndrome
Jean-Emmanuel Kahn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
Sophia Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Human airway smooth muscle promotes eosinophil differentiation
A. I. Fanat et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses
Gail M. Gauvreau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
Marc E. Rothenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
Patrick Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Thymic stfomal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells
Zoulfia Allakhverdi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Anti-interieukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
JK Garrett et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma - A pilot study 164/rccm.200206-5250C
JC Kips et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions
C Büttner et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis
P Gevaert et al.
ALLERGY (2003)
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway
PT Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK
PE Moore et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism
S Matsukura et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
MJ Leckie et al.
LANCET (2000)
Mechanisms of eosinophil-associated inflammation
GJ Gleich
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Evidence for local eosinophil differentiation within allergic nasal mucosa: Inhibition with soluble IL-5 receptor
L Cameron et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
